FDCA Raids Surat Firms Selling Fake Skin Products

Ahmedabad: Gujarat FDCA, in its third raid on fake allopathic drugs and cosmetics in the state in the last two months, busted three firms, all linked, in Surat for selling counterfeit skin creams by misbranding them as having been manufactured by a major pharmaceutical company. They were found selling these fake products on Amazon.

A total of 14 samples were taken and sent for analysis during the investigation. Further investigations have been started by confiscating the valuables worth more than Rs 30 lakh from the three firms.
​​​​​​​
On the basis of a complaint and bill of sale from the online marketplace that DEMELAN Cream 50 gm drug was being sold on Amazon by a firm in Surat, the FDCA raided Ayushi Enterprises, RJ Enterprise and Cairo Biotech and arrested their owners.

Related Posts

KGMU prof suspended for forcing patients to buy meds from pvt store

Lucknow: Faculty member in the ophthalmology department of KGMU, Prof Sanjiv Gupta, was suspended on charges of prescribing medicines and lenses for cataract surgery that were available at a private…

CDSCO receives 1,387 adverse drug reaction reports in nine months of 2025

New Delhi: The pharmacovigilance division of the Central drug regulator has received a total of 1,387 adverse reports, with the highest regarding fixed dose combinations (FDCs), and a total of…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

KGMU prof suspended for forcing patients to buy meds from pvt store

KGMU prof suspended for forcing patients to buy meds from pvt store

World Record in Robotic Tele-Surgery takes Intercontinental Leap of 20,000 Km

World Record in Robotic Tele-Surgery takes Intercontinental Leap of 20,000 Km

CDSCO receives 1,387 adverse drug reaction reports in nine months of 2025

CDSCO receives 1,387 adverse drug reaction reports in nine months of 2025

NGT issues notice to Himachal pharma unit over pollution, water diversion allegations

NGT issues notice to Himachal pharma unit over pollution, water diversion allegations

Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concerns

Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concerns

DGFT Fixes Six New Standard Input Output Norms (SIONs) for Pharmaceutical and Chemical Exports

DGFT Fixes Six New Standard Input Output Norms (SIONs) for Pharmaceutical and Chemical Exports